Following proceedings commenced by the Australian Securities and Investments Commission (ASIC), the Federal Court declared on 28 October 2024 that a term used by HCF Life Insurance Company Pty Ltd (HCF Life) in consumer contracts was misleading, but not an unfair contract term.
The HCF Life case follows a number of other high profile cases following reforms to the unfair contract terms regime in 2023, and provides guidance on determining whether a term is ‘reasonably necessary’ to protect a business’s ‘legitimate interests’. The decision adds to a growing body of jurisprudence on when contract terms in a consumer or small business contract may be unfair and unlawful, and is a timely reminder for businesses to complete contract reviews to ensure their documentation continues to be compliant.
It also highlights the importance of providing accurate and complete information to customers, particularly in the insurance sector, with ASIC Deputy Chair Sarah Court stating that:
“consumers rightly expect that insurers will provide accurate information to them about their rights. Consumers rely on this information to make insurance claims, often in trying personal circumstances”.
The defined term and provision in question before the Federal Court concerned exclusions for a pre-existing condition in Product Disclosure Statements for various HCF Life income protection, recovery and life insurance products (Pre-Existing Condition Terms).
The Pre-Existing Condition Terms had been varied four times since August 2019, however the current Pre-Existing Condition Term had the effect of excluding HCF’s liability to pay the consumer a benefit if a ‘pre-existing condition’ existed. A pre-existing condition was defined as “any condition, illness or ailment where the signs or symptoms of which in the opinion of a registered medical practitioner, existed at any time before the Cover Commencement Date, even if a diagnosis had not been made”. A pre-existing condition therefore included conditions of which the consumer was not aware.
ASIC’s foundational allegation was that the Pre-existing Condition Terms are rendered partially unenforceable by section 47 of the Insurance Contracts Act 1984 (Cth) (ICA), which states that:
“where, at the time when the contract was entered into, the insured was not aware of, and a reasonable person in the circumstances could not be expected to have been aware of, the sickness or disability, the insurer may not rely on a provision included in the contract that has the effect of limiting or excluding the insurer’s liability under the contract by reference to a sickness or disability to which the insured was subject at a time before the contract was entered into”.
In such circumstances, ASIC further alleged that:
Justice Jackman determined that ASIC’s foundational allegation that the Pre-Existing Condition Terms was partially unenforceable under the ICA given the Pre-Existing Condition Terms were fundamentally different to the requirement under section 47 of the ICA and would (in certain circumstances) yield different outcomes (our emphasis):
“On the one hand, the Pre-Existing Condition Terms turn upon whether a registered medical practitioner holds a subjective opinion that the signs or symptoms of a condition, illness or ailment existed before the policy was entered into. On the other, s 47 of the ICA asks whether the insured was aware (or a reasonable person in the circumstances could be expected to have been aware) of the underlying sickness at the time of contracting…”
In consideration of the High Court’s four steps to assess misleading or deceptive conduct in trade or commerce,[1] the Federal Court ultimately concluded that HCF Life had contravened section 12DF(1) of the ASIC Act, which provides that:
“a person must not, in trade or commerce engage in conduct that is liable to mislead the public as to the nature, the characteristics, the suitability for their purpose or the quantity of any financial services”.
Publishing each Product Disclosure Statement, giving the Product Disclosure Statements to members of the public, and entering into the contracts with members of the public, amounted to engaging in conduct that was ‘liable to mislead’ in circumstances where the Product Disclosure Statements:
As to the meaning conveyed by the relevant conduct, Justice Jackman accepted ASIC’s submission that an ordinary and reasonable member of the public would read and understand the Pre-Existing Condition Terms to be an accurate and complete statement of when benefits would not be payable by reason of a pre-existing condition including because such terms were absolute and unqualified. Furthermore, an ordinary and reasonable reader would be ignorant of the potential effect of section 47 of the ICA including (as discussed by Justice Jackman in his rejection of other submissions by HCF Life) on the basis that the Product Disclosure Statements did not make reference to any terms being unenforceable or subject to the application of other laws.
The Federal Court agreed that the meaning conveyed by the relevant conduct was misleading in circumstances where section 47(2) of the ICA would render the Pre-Existing Condition Terms partially unenforceable. Furthermore, an omission to mention a qualification in such circumstances is also conduct that is regarded as misleading.[2] HCF Life’s submission that section 12DF of the ASIC Act requires the public to be misled to their detriment was rejected; Justice Jackman opined that ordinary and reasonable readers who remain unaffected by the Pre-Existing Condition Terms would still have been misled by HCF Life’s conduct.
The Federal Court concluded that the Pre-Existing Condition Terms ultimately did not satisfy all three threshold requirements for a clause to be considered ‘unfair’ under section 12BF of the ASIC Act.
The Court determined that:
Helpfully, in rejecting ASIC’s submission that the Pre-Existing Terms were not transparent, the Federal Court clarified that section 12BG(2)(b) of the ASIC Act requires inquiry on the extent to which the term is transparent, not the extent to which the parties’ rights and obligations are transparent.
The Federal Court accepted that an assessment of reasonably necessary is not a test of the term being included or excluded, and that it may take into account other options available to the party to protect its business that are less restrictive to the other party. However, Justice Jackman cautioned that the existence of a reasonable alternative is only relevant if it would have caused a significantly lesser imbalance in the parties’ rights and obligations. For this reason, the Federal Court concluded that the reasonable alternatives available to HCF Life were not relevant considerations as the balance of the parties’ rights and obligations under the Pre-Existing Condition Terms were identical.
ASIC is seeking penalties in relation to the misleading conduct. The decision provides useful guidance in relation to ensuring public documentation, material and contracts accurately reflect any legal rights or obligations and does not mislead consumers (particularly vulnerable persons).
The Federal Court’s assessment of the provisions from an unfair contract terms perspective also provides useful guidance, particularly in relation to:
As the new year commences, businesses should continue to consider whether their standard form contracts are, or continue to be, aligned with the law on unfair contract terms and, more generally, with the law on misleading or deceptive conduct. Please contact Gadens’ consumer law team should you have any questions or require assistance.
If you found this insight article useful and you would like to subscribe to Gadens’ updates, click here.
Authored by:
Adam Walker, Partner
Breanna Davies, Partner
Edward Martin, Partner
Eve Lillas, Senior Associate
Brittany Dorney, Associate
[1] Self Care IP Holdings Pty Ltd v Allergan Australia Pty Ltd [2023] HCA 8; (2023) 408 ALR 195 at [80]-[84].
[2] Rhone-Poulenc Agrochimie SA v UIM Chemical Services Pty Ltd (1986) 12 FCR 477 at 489-90.